hydroxychloroquine has been researched along with Anemia in 5 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Stevens-Johnson syndrome and toxic epidermal necrolysis are life-threatening dermatological conditions." | 1.42 | [Systemic lupus erythematosus presenting as Stevens-Johnson syndrome]. ( Bellakhal, S; Ben Kaab, B; Derbel, F; Douggui, MH; Souissi, A; Teyeb, Z, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gómez-Enjuto, S | 1 |
| Hernando-Requejo, V | 1 |
| Lapeña-Motilva, J | 1 |
| Ogando-Durán, G | 1 |
| Fouz-Ruiz, D | 1 |
| Domingo-García, J | 1 |
| Rodríguez-García, E | 1 |
| Cemillán-Fernández, CA | 1 |
| Dar, SA | 1 |
| Wahid, M | 1 |
| Haque, S | 1 |
| Almalki, SS | 1 |
| Akhter, N | 1 |
| Bellakhal, S | 1 |
| Ben Kaab, B | 1 |
| Teyeb, Z | 1 |
| Souissi, A | 1 |
| Derbel, F | 1 |
| Douggui, MH | 1 |
| Yuan, Y | 1 |
| Ma, H | 1 |
| Ye, Z | 1 |
| Jing, W | 1 |
| Jiang, Z | 1 |
| MCDUFFIE, FC | 1 |
5 other studies available for hydroxychloroquine and Anemia
| Article | Year |
|---|---|
Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient.
Topics: Aged; Anemia; Anticoagulants; Anticonvulsants; Antiviral Agents; Betacoronavirus; Calcium Channel Bl | 2020 |
Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA).
Topics: Anemia; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Hu | 2020 |
[Systemic lupus erythematosus presenting as Stevens-Johnson syndrome].
Topics: Adult; Anemia; Arthralgia; Autoantibodies; Complement C3; Critical Care; Facial Dermatoses; Female; | 2015 |
Interferon-stimulated gene 15 expression in systemic lupus erythematosus : Diagnostic value and association with lymphocytopenia.
Topics: Adult; Aged; Anemia; Case-Control Studies; Connective Tissue Diseases; Correlation of Data; Cytokine | 2018 |
BONE MARROW DEPRESSION AFTER DRUG THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
Topics: Adolescent; Agranulocytosis; Anemia; Anemia, Aplastic; Anti-Bacterial Agents; Bone Marrow; Bone Marr | 1965 |